Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total glucosides of paeony capsules plus prednisone for oral lichen planus
ChiCTR-IPR-16010156Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of total glucosides of paeony and prednisone in oral lichen planus (OLP) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Effective rate of treatment. Started Dec 2016; status: recruiting.
02
Drugs
total glucosides of paeonyprednisone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on ChiCTR-IPR-16010156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16010156.